Digital AI and the Big Data paradigm – big ambitions in novel drug d... Over the past few decades, data generation has veritably exploded.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
